MIF and pulmonary arterial hypertension: Curative treatments with the MIF antagonist ISO-1 or anti-CD74 neutralizing antibodies partially reversed the development of pulmonary hypertension and substantially reduced inflammatory cell infiltration in the rat monocrotaline model of PAH [59].